A Prospective Study of 18FDG-PET With CT Coregistration for Radiation Treatment Planning of Lymphomas and Other Hematologic Malignancies

被引:11
|
作者
Terezakis, Stephanie A. [1 ,4 ]
Schoeder, Heiko [2 ]
Kowalski, Alexander [1 ]
McCann, Patrick [1 ]
Lim, Remy [2 ]
Turlakov, Alla [2 ]
Gonen, Mithat [3 ]
Barker, Chris [1 ]
Goenka, Anuj [1 ]
Lovie, Shona [1 ]
Yahalom, Joachim [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Nucl Med, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Stat, New York, NY 10065 USA
[4] Johns Hopkins Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; RADIOTHERAPY; GUIDELINES; INDOLENT; FIELDS; IMPACT; PET;
D O I
10.1016/j.ijrobp.2014.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This prospective single-institution study examined the impact of positron emission tomography (PET) with the use of 2-[F-18] fluoro-2-deoxyglucose and computed tomography (CT) scan radiation treatment planning (TP) on target volume definition in lymphoma. Methods and Materials: 118 patients underwent PET/CT TP during June 2007 to May 2009. Gross tumor volume (GTV) was contoured on CT-only and PET/CT studies by radiation oncologists (ROs) and nuclear medicine physicians (NMPs) for 95 patients with positive PET scans. Treatment plans and dose-volume histograms were generated for CT-only and PET/CT for 95 evaluable sites. Paired t test statistics and Pearson correlation coefficients were used for analysis. Results: 70 (74%) patients had non-Hodgkin lymphoma, 10 (11%) had Hodgkin lymphoma, 12 (10%) had plasma-cell neoplasm, and 3 (3%) had other hematologic malignancies. Forty-three (45%) presented with relapsed/refractory disease. Forty-five (47%) received no prior chemotherapy. The addition of PET increased GTV as defined by ROs in 38 patients (median, 27%; range, 5%-70%) and decreased GTV in 41 (median, 39.5%; range, 5%-80%). The addition of PET increased GTV as defined by NMPs in 27 patients (median, 26.5%; range, 5%-95%) and decreased GTV in 52 (median, 70%; range, 5%-99%). The intraobserver correlation between CT-GTV and PET-GTV was higher for ROs than for NMPs (0.94, P <.01 vs 0.89, P <.01). On the basis of Bland-Altman plots, the PET-GTVs defined by ROs were larger than those defined by NMPs. On evaluation of clinical TPs, only 4 (74%) patients had inadequate target coverage (D95 < 95%) of the PET-GTV defined by NMPs. Conclusions: Significant differences between the RO and NMP volumes were identified when PET was coregistered to CT for radiation planning. Despite this, the PET-GTVdefined by ROs and NMPs received acceptable prescription dose in nearly all patients. However, given the potential for a marginal miss, consultation with an experienced PET reader is highly encouraged when PET/CT volumes are delineated, particularly for questionable lesions and to assure complete and accurate target volume coverage. (C) 2014 Elsevier Inc.
引用
收藏
页码:376 / 383
页数:8
相关论文
共 50 条
  • [21] STAGING NEWLY DIAGNOSED LYMPHOMAS: COMPARISON BETWEEN WHOLE BODY-MRI/DWIBS AND 18FDG-PET/CT
    Minoia, C.
    Ficco, M.
    Maggialetti, N.
    Ferrari, C.
    Iuele, F.
    Buquicchio, C.
    Tarantini, G.
    Iacobazzi, A.
    Lapietra, A.
    Merchionne, F.
    Florio, C.
    Rubini, G.
    Guarini, A.
    HAEMATOLOGICA, 2013, 98 : 358 - 358
  • [22] The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma:: A prospective study
    Mah, K
    Caldwell, CB
    Ung, YC
    Danjoux, CE
    Balogh, JM
    Ganguli, SN
    Ehrlich, LE
    Tirona, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02): : 339 - 350
  • [23] 18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
    Mikhaeel, NG
    Timothy, AR
    Hain, SF
    O'Doherty, MJ
    ANNALS OF ONCOLOGY, 2000, 11 : 147 - 150
  • [24] Characterization of malignant lesions with DWI, using 18FDG-PET/CT as standard: Feasibility study
    Betti, M.
    Biagini, C.
    Biagini, C.
    Orlandini, L. C.
    Natale, L.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S246 - S246
  • [25] Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by 18FDG-PET/CT
    Mazzola, Rosario
    Fiorentino, Alba
    Di Paola, Gioacchino
    Levra, Niccolo Giaj
    Ricchetti, Francesco
    Fersino, Sergio
    Tebano, Umberto
    Pasetto, Stefano
    Ruggieri, Ruggero
    Salgarello, Matteo
    Alongi, Filippo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) : 547 - 555
  • [26] A prospective study comparing CT-Based to PET/CT-based radiation treatment planning
    Bradley, K. A.
    Kruser, T. J.
    Bentzen, S. M.
    Anderson, B. M.
    Gondi, V.
    Khuntia, D.
    Perlmann, S.
    Mehta, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S68 - S69
  • [27] Incidental F-18-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies
    Czepczynski, Rafal
    Stangierski, Adam
    Oleksa, Robert
    Janicka-Jedynska, Malgorzata
    Czarnywojtek, Agata
    Ruchala, Marek
    Sowinski, Jerzy
    NUCLEAR MEDICINE REVIEW, 2011, 14 (02) : 68 - 72
  • [28] IMRT with 18FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer
    Nikola Cihoric
    Coya Tapia
    Kamilla Krüger
    Daniel M Aebersold
    Bernd Klaeser
    Kristina Lössl
    Radiation Oncology, 9
  • [29] 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields:: A planning study
    van Loon, Judith
    Offermann, Claudia
    Bosmans, Geert
    Wanders, Rinus
    Dekker, Andre
    Borger, Jacques
    Oellers, Michel
    Dingemans, Anne-Marie
    van Baardwijk, Angela
    Teule, Jaap
    Snoep, Gabriel
    Hochstenbag, Monique
    Houben, Ruud
    Lambin, Philippe
    De Ruysscher, Dirk
    RADIOTHERAPY AND ONCOLOGY, 2008, 87 (01) : 49 - 54
  • [30] Clinical impact of 18FDG-PET and PET/CT in the evaluation of pathologic response after treatment in oesophageal cancer's patient
    Gasparini, M. D.
    Florimonte, L.
    Valisi, E.
    Leo, R.
    Benti, R.
    Gerundini, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S178 - S178